2025-05-21 REL RCSB INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY INITIAL_RELEASE REPOSITORY EXPERIMENTAL_SUMMARY em_admin em_software _em_admin.last_update _em_software.name STRUCTURE_SUMMARY em_admin pdbx_entry_details pdbx_modification_feature _em_admin.last_update _pdbx_entry_details.has_protein_modification DATA_COLLECTION em_admin em_software _em_admin.last_update _em_software.name RCSB RCSB 2022-11-23 2024-05-15 2024-05-15 2025-05-21 Bill & Melinda Gates Foundation OPP1115782/INV-002916 United States National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID) A1144462 United States HIV Env germline targeting BG505_MD64_N332-GT5 SOSIP in complex with V3-glycan polyclonal Fab isolated from immunized wild type mice, and NHP monoclonal Fab RM20A3 Ozorowski G Ward AB mouse antibody, germline targeting, HIV-1, vaccine design, polyclonal, VIRAL PROTEIN-IMMUNE SYSTEM complex Xie Z Lin YC Steichen JM Ozorowski G Kratochvil S Ray R Torres JL Liguori A Kalyuzhniy O Wang X Warner JE Weldon SR Dale GA Kirsch KH Nair U Baboo S Georgeson E Adachi Y Kubitz M Jackson AM Richey ST Volk RM Lee JH Diedrich JK Prum T Falcone S Himansu S Carfi A Yates 3rd JR Paulson JC Sok D Ward AB Schief WR Batista FD mRNA-LNP HIV-1 trimer boosters elicit precursors to broad neutralizing antibodies. Science US 384 eadk0582 eadk0582 2024 38753770 doi:10.1126/science.adk0582 1095-9203 0038 SCIEAS EMD-28942 other EM volume 8f9m FULLOVERLAP HIV Env germline targeting BG505_MD64_N332-GT5 SOSIP in complex with V3-glycan polyclonal Fab isolated from immunized wild type mice, and NHP monoclonal Fab RM20A3 HIV Env germline targeting BG505_MD64_N332-GT5 SOSIP in complex with V3-glycan polyclonal Fab isolated from immunized wild type mice, and NHP monoclonal Fab RM20A3 0 1 2 3 4 5 6 Mus musculus BG505_MD64_N332-GT5 gp120 synthetic construct 0.054236800999999994 3 Homo sapiens LEVO AENLWVTVYYGVPVWKDAETTLFCASDAKAYETEKHNVWATHACVPTDPNPQEIHLENVTEEFNMWKNNMVEQMHEDIIS LWDQSLKPCVKLTPLCVTLQCTNYAPKLRSMMRGEIKNCSFNMTTELRDKKQKVYSLFYRLDVVQINENQGNRSNNSNKE YRLINCNTSAITQACPKVSFEPIPIHYCAPAGFAILKCKDKKFNGTGPCPSVSTVQCTHGIKPVVSTQLLLNGSLAEEEV IIRSENITNNAKNILVQLNTPVQINCTRPSNNTVKSIRIGPGQAFYYFGDVLGHVRMAHCNISKATWNETLGKVVKQLRK HFGNNTIIRFAQSSGGDLEVTTHSFNCGGEFFYCNTSGLFNSTWISNTSVQGSNSTGSNDSLILPCWIKQIINMWQRIGQ AMYAPPIQGVIRCVSNITGLILTRDGGSTNSTTETFRPGGGDMRDNWRSELYKYKVVKIEPLGVAPTRCKRRVVGRRRRR R RM20A3 Fab Heavy Chain Macaca mulatta 0.013511111000000001 3 Homo sapiens LEVO EVQLVETGGGLVQPGGSLKLSCRASGYTFSSFAMSWVRQAPGKGLEWVSLINDRGGLTFYVDSVKGRFTISRDNSKNTLS LQMHSLRDGDTAVYYCATGGMSSALQSSKYYFDFWGQGALVTVSS RM20A3 Fab Light Chain Macaca mulatta 0.013508799999999998 3 Homo sapiens LEVO ALTQPPSVSGSPGQSVTISCTGTSSDIGSYNYVSWYQQHPGKAPKLMIYDVTQRPSGVSDRFSGSKSGNTASLTISGLQA DDEADYYCSAYAGRQTFYIFGGGTRLTVLGQPKASPTVTLFPPSSEEL BG505_MD64_N332-GT5 gp41 synthetic construct 0.018250541 3 Homo sapiens LEVO AVGIGAVSLGFLGAAGSTMGAASMTLTVQARNLLSGIVQQQSNLLRAPEPQQHLLKDTHWGIKQLQARVLAVEHYLRDQQ LLGIWGCSGKLICCTNVPWNSSWSNRNLSEIWDNMTWLQWDKEISNYTQIIYGLLEESQNQQEKNEQDLLALDGTKHHHH HH V3-glycan epitope polyclonal Fab heavy chain Mus musculus 0.009634868 1 LEVO (UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK) (UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK) (UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK) (UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK) (UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK) (UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK) (UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK) (UNK) V3-glycan epitope polyclonal Fab light chain Mus musculus 0.009379552999999999 1 LEVO (UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK) (UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK) (UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK) (UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK) (UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK) (UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK) (UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK)(UNK) 2-acetamido-2-deoxy-beta-D-glucopyranose 0.000221208 42 NAG singleParticle particle 7.0 7.4 UltrAuFoil R1.2/1.3 GOLD GOLD HOLEY PLASMA CLEANING ETHANE 100 277 FEI VITROBOT MARK IV TFS GLACIOS FLOOD BEAM BRIGHT FIELD FIELD EMISSION GUN 200 0.7000000000000001 1.5 190000.0 FEI TITAN KRIOS AUTOGRID HOLDER FEI FALCON IV (4k x 4k) 40.0 1 cryoSPARC 3.2 Patch CTF PHASE FLIPPING AND AMPLITUDE CORRECTION 4ZMJ C1 4.1 FSC 0.143 CUT-OFF cryoSPARC 3.2 Local Refinement 11058 MAXIMUM LIKELIHOOD MAXIMUM LIKELIHOOD RELION 3.1
focused classifications over Fab density with skip align
 emd_28945.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 416 416 416 0 0 0 416 416 416 435.01117 435.01117 435.01117 90.0 90.0 90.0 X Y Z -0.28813335 0.6358233 0.00057503924 0.021813707 1.0457 1.0457 1.0457 0.13 AUTHOR sharpened map emd_28945_msk_1.map emd_28945_half_map_2.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 416 416 416 0 0 0 416 416 416 435.01117 435.01117 435.01117 90.0 90.0 90.0 X Y Z -3.1951797 2.843111 0.0005218001 0.36284894 1.0457 1.0457 1.0457 AUTHOR half map B emd_28945_half_map_1.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 416 416 416 0 0 0 416 416 416 435.01117 435.01117 435.01117 90.0 90.0 90.0 X Y Z -2.8632355 2.8220782 0.00056093285 0.36917686 1.0457 1.0457 1.0457 AUTHOR half map A